The skin is the largest organ in the human body and is indispensable in its function as a physical barrier to foreign
substances. It is comprised of two layers, the epidermis and dermis. The epidermis is the outermost layer containing
keratinocytes and melanocytes. Keratinocytes provide a mechanical barrier to protect underlying tissues while
melanocytes are responsible for skin pigmentation. This is also the same layer that contains the oil and sweat glands.
Meanwhile, the dermis is the innermost layer of the skin and consists of collagen, which is produced by fibroblast
cells. This later is flexible and its main role is to regulate temperature and supply the epidermis with nutrientsaturated blood. The dermis is also the location of hair follicle base, nerve endings, and pressure receptors. Lastly,
this bottom layer defends the body against infections that pass through the epidermis, the first defense against
disease.
At the outermost level, molecules to be delivered can
penetrate through three different pathways to viable
tissue. They can pass through hair follicles with
associated sebaceous glands, or through sweat ducts, or
across the continuous stratum corneum between these
While the exact mechanisms of skin transfer are yet to be completely understood, three routes of penetration have
been hypothesized:
Intercellular Skin Absorption, which occurs between the cells of the stratum corneum, the outermost
layer of the skin
Transcellular Skin Absorption, where substances actually pass through the skin cells themselves
Skin Absorption Through the Follicles and Glands, also known as appendageal absorption, which may
also exhibit reservoir effects in which substances may be stored within the glands for absorption over time
While the skin does act as a barrier, it is not a complete barrier. Many chemicals do penetrate
the skin, either intentionally or unintentionally, and cutaneous metabolism does occur. Because
of its large surface area, the skin may be a major route of entry into the body in some exposure
situations.
This major route of entry has become a concern in many circumstances where toxic substances are released into
air, water, and even city water supplies.
The California Environmental Protection Agency issued a report entitled Chlorinated Chemicals in Your
Home, warning of the risks of cancer due to chlorinated chemicals. The agency issued the statement: Taking a
long, hot shower in a typical small shower stall can substantially increase your exposure to chloroform. If you use
indoor spas, hot tubs, or swimming pools, you are also likely to be exposed to high levels of chloroform.2
Health Canada has estimated that skin exposure to certain toxic hydrocarbons in the Great Lakes may be
as dangerous as oral exposure, issuing alerts to bathers, especially those affected by sunburn, which may
enhance absorption.3
Worker safety is an issue. Workers in various industries have suffered poisoning, in some cases fatal, from
substances penetrating exclusively through the skin and into the bloodstream, such as through dermal exposure to
leaded gasoline and insecticides.4
The European Commission and the World Health Organization have both issued Guidance Documents,
such as the Guidance Document on Dermal Absorption and International Programme on Chemical
Safety Environmental Health Criteria serve to instruct agencies on how to protect workers from exposure to toxic
compounds.
While government agencies such as those above work to stop the transfer of chemicals through the skin, transdermal
drug delivery methods seek to take advantage of it. Transdermal patches are produced as delivery systems for
nicotine, hormones, pain killers, and others.
These methods are coveted for their clear advantages over oral medications, as outlined by Stanley Scheindlin,
pharmaceutical chemist, in the journal Molecular Interventions:
Patients often forget to take their medicine, and even the most faithfully compliant get tired of
swallowing pills, especially if they must take several each day. Additionally, bypassing the
gastrointestinal (GI) tract would obviate the GI irritation that frequently occurs and avoid partial
first-pass inactivation by the liver.
While transdermal drugs are well known in the medical community, the difference with magnesium oil topical
treatments is, of course, the fact that magnesium is an essential mineral to the human body, in a natural form. Thus,
use of topical magnesium oil products brings all the advantages of transdermal applications, but none of the
disadvantages of introducing foreign substances into the body.
Transdermal magnesium is a needed substance. While the chemicals in transdermal pharmaceuticals are actively
filtered, inactivated, and excreted by the bodys detoxification systems, magnesium is welcomed and actively taken in
by the cells.
3 Routes of Penetration
Figure 3 illustrates the possible pathways for a penetrant to cross
the skin barrier. Accordingly, a molecule may use two diffusion
routes to penetrate normal intact human skin: the appendageal
route and the trans-epidermal route.
The appendageal route comprises transport via the sweat glands
and the hair follicles with their associated sebaceous glands. These
routes circumvent penetration through the stratum corneum and are
therefore known as shunt routes.
Although these routes offer high permeability, they are considered
to be of minor importance because of their relatively small area,
approximately 0.1% of the total skin area. The appendageal route
seems to be most important for ions and large polar molecules
which hardly permeate through the stratum corneum [4].
Trans-epidermal transport means that molecules cross the intact
horny layer. Two potential micro-routes of entry exist, the
transcellular (or intracellular) and the intercellular pathways (Figure
4).
The principal pathway taken by a penetrant is decided mainly by
the partition coefficient (log K). Hydrophilic drugs partition
preferentially into the intracellular domains, whereas lipophilic
permeants (octanol/water log K > 2) traverse the stratum corneum
via the intercellular route. Most molecules pass the stratum
corneum by both routes. However, the tortuous intercellular
pathway is widely considered to provide the principal route and
major barrier to the permeation of most drugs [5].
Considering that the skin is such a heterogeneous membrane, it is
surprising that simple diffusion laws can be used to describe the
transport through the skin.
J=
KD
h
(Co Ci)
Removal of a solvent
Reaction of two or more solutes to produce a compound which is less soluble
Example/Constituents
Effect on
skin hydratation
Effect on skin
permeability
Marked increase
Marked increase
Absorption bases
Marked increase
Absorption bases
Marked increase
Lipohihc vehicles
W/O systems
O/W systems
Humectants
Powder
W/O creams
W/O emulsions
Increase
W/O creams
W/O emulsions
Slight increase
Water-soluble vehicles:
gylcerol, glycols
Possible decrease or
act
as chemical enhancer
coefficient
Disruption of the lipid bilayer structure
4.4.2 Iontophoresis
The basic principle of iontophoresis is that a small
electric current is applied to the skin. This provides
the driving force to primarily enable penetration of
charged molecules into the skin. A drug reservoir is
placed on the skin under the active electrode with the
same charge as the penetrant. An indifferent counter
electrode is positioned elsewhere on the body.
The active electrode effectively repels the active
substance and forces it into the skin (Figure 7). This
simple electrorepulsion is known as the main
mechanism responsible for penetration enhancement
by iontophoresis. The number of charged molecules
which are moved across the barrier correlates
directly to the applied current and thus can be
controlled by the current density.
Other factors include the possibility to increase the permeability of the skin barrier in the presence of a
flow of electric current and electroosmosis.
4.4.4 Microneedles
In the last years, several attempts have been made
to enhance the transport of substances across the
skin barrier using minimally invasive techniques [10].
The proper function of an appropriate system
requires that the thickness of the stratum corneum
( 10 to 20 m) has to be breached. More recent
developments focus on the concept of microneedles.
Microneedles are needles that are 10 to 200 m in
height and 10 to 50 m in width (Figure 9). They are
solid or hollow and are connected to a reservoir
which contains the active principle.
Microneedle arrays are applied to the skin surface so
that they pierce the upper epidermis far enough to
Figure 9: Basic design of microneedle deliver devices. Needles
increase skin permeability and allow drug delivery,
of approximately with or without centre hollow channels are placed
but too short to cause any pain to the receptors in the onto the skin surface so that they penetrate the stratum corneum
and epidermis without reaching the nerve endings present in the
dermis. Therefore there is no limitation concerning
upper dermis.
polarity and molecular weight of the delivered
molecules. The fabrication of such tiny structures
became possible with the advent of micromachining
technology which is an essential technology for the
microelectronic industry.
It is not difficult to imagine that microneedle systems can be easily combined with microelectronic
elements which can fully control the delivery rate. Furthermore, this type of system could be linked to a
micro sensor system which measures the actual concentration of an active molecule which then triggers
the release. It can be envisioned that such a pharmacy on a chip may be the future of drug delivery.
4.5 Formulation approaches
Penetration enhancement with special formulation
approaches is mainly based on the usage of colloidal
carriers. Submicron sized particles are intended to
transport entrapped active molecules into the skin.
Such carriers include liposomes, nanoemulsions, and
solid-lipid nanoparticles (Figure 10) [11]. Most reports
cite a localizing effect whereby the carriers
accumulate in stratum corneum or other upper skin
layers. Generally, these colloidal carriers are not
expected to penetrate into viable skin. However, the
effectiveness of these carriers is still under debate.
More recently a new type of liposomes called transferosomes has been introduced [12, 13].
Transferosomes consist of phospholipids, cholesterol and additional surfactant molecules such as
sodium cholate. The inventors claim that transferesomes are ultradeformable and squeeze through pores
less than one-tenth of their diameter. Thus 200 to 300 nm sized transfereosmes are claimed to penetrate
intact skin. Penetration of these colloidal particles works best under in vivo conditions and requires a
hydration gradient from the skin surface towards the viable tissues.
Another formulation approach aiming to enhance skin penetration is the preparation of microemulsions.
Such systems consist of water, oil, and amphiphilic compounds (surfactant and co-surfactant) which yield
a transparent, single optically isotropic, and thermodynamically stable liquid. Microemulsions can be
either oil continuous, water continuous, or bi-continuous. The main difference between macroemulsions
and microemulsions lies in the size of the particles of the dispersed phase: these are at least an order of
magnitude smaller in the case of microemulsions ( 10 200 nm) than those of conventional emulsions (1
20 m). Typical properties of microemulsions include optical transparency, thermodynamic stability, and
and
Nanotechnology
as
Nanoparticles).
Unfortunately, a
OF
DRUG
DELIVERY
THROUGH
SKIN
The drug release process mainly consists of four stages: the drug
releases from the formulation, diffuses across the stratum corneum
(SC) via tortuous intercellular lipid path-way, transfers from SC into
epidermis, and then enters the systemic circulation via capillary
network.
APPROACHES
Iontophoresis
APPROACHES
enhancers:
a)
Solvents
b)
Surfactants
These
include
the
following:
Anionic
surfactants
Cationic
surfactants
* Bile salts
c)
Binary systems
d)
Miscellaneous chemicals
of
delivering
low
molecular
weight
drugs
as
well
as
Allows
strict
control
of
transdermal
penetration
rates.
Reduction
of
dosing
frequency
and
patient
compliance.
Reduction
indices.
of
fluctuations
in
plasma
levels
of
drugs.
of
vomiting,
diarrhea.
Permit both local and systemic effects and less risk of systemic
absorption
than
injection.